These results collectively indicate that amygdalin dynamically regulates key effector molecules such as D-chiro-inositol, betaine, and LysoPC through ABC transporters and choline metabolism in cancer, thereby activating the antioxidant system, enhancing immune function, and improving production performance. The gene discussed is ABCG2; the disease is cancer.